Patent ID: 8053455

Claim:
A compound having the general formula: wherein R is Y is selected from the group consisting of and —C(R 1 H)OC(O)X((CR 12 R 13 )—(CHR 10 ) m —(CH 2 ) n —Z p —(CH 2 ) q —(CHR 11 ) r —(CR 16 R 17 ))—R 5 ; 2) Z is —O— or —(CR 14 R 15 )—; m, n, p, q, and r are independently selected from the group consisting of 0 and 1; X is —O— or —(CR 18 R 19 )—; R 1 is selected from the group consisting of hydrogen, C 1-4 alkyl, aryl, C 1-4 alkylarylene, and arylC 1-4 alkylene; R 5 is —O—N═N(O)—NR 3 R 4 ; R 3 and R 4 are independently selected from the group consisting of unsubstituted or substituted C 1-6 alkyl, unsubstituted or substituted C 1-6 alkenyl, unsubstituted or substituted morpholino, amino, unsubstituted or substituted benzyl, unsubstituted or substituted phenyl, unsubstituted or substituted arylC 1-4 alkyl, or R 3 and R 4 together with the nitrogen atom to which they are attached, form a ring selected from the group consisting of Q is selected from the group consisting of —(CR 20 R 21 )—, —S—, —N(R 6 )— and O—; R 6 is selected from the group consisting of hydrogen, unsubstituted or substituted C 1-6 alkyl, and —COOR 22 ; R 8 , R 9 and R 22 are independently selected from the group consisting of hydrogen and unsubstituted or substituted C 1-6 alkyl; R 10 and R 11 are independently selected from the group consisting of hydrogen and unsubstituted or substituted C 1-6 alkyl; R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 and R 21 are independently selected from the group consisting of hydrogen, unsubstituted or substituted C 1-6 alkyl, and unsubstituted or substituted aryl; or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of the stereoisomer thereof.